Of 206 patients who were randomized, 152 completed phase 1, and 105 of these patients were randomly assigned to phase 2 (68 received tacrolimus ointment and 37 received vehicle).

• 随机选取的206患者中152人完成了第一阶段，其中105人被随机指定进入第二阶段（68人接受他克莫司治疗37人接受赋形剂）。